Skip to main content
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2009:169–183. doi: 10.1007/978-3-540-76660-5_11

Inflammatory Diseases of the Meninges

Stefan Rohde 2
Editor: Stefan Hähnel1
PMCID: PMC7119920

Abstract

Neuroimaging is of major importance in all cases of suspected infectious meningitis in order to get quick information about the extent of the disease, typical lesion patterns, and potential complications, such as hydrocephalus, involvement of the underlying brain parenchyma, or vasculitis. In bacterial meningitis, abnormal and asymmetrical enhancement of the leptomeninges and the subarachnoid space is typical. Initial neuroimaging has to rule out infectious foci of the skull base such as purulent sinusitis or mastoiditis. In patients with focal deficits or seizures, MRI is the tool of choice to diagnose vascular or septic complications. Neoplastic, viral, or fungal infections of the CNS may present with similar changes of the meninges; however, fungal meningitis normally causes a thicker and more nodular enhancement. In case of basal accentuation of the leptomeningeal contrast enhancement and conspicuous signal changes in the basal cisterns, one has to consider tuberculous meningitis for differential diagnosis, especially in patients with HIV infection. Non-infectious causes of meningeal enhancement comprise several primary and secondary tumors (e.g., CNS lymphoma, medulloblastoma, or breast cancer), granulomatous diseases, and post-operative changes.

Keywords: Bacterial Meningitis, Cranial Nerve Palsy, Pneumococcal Meningitis, Tuberculous Meningitis, Intracranial Hypotension

References

  1. Brightbill TC, Ihmeidan IH, Post MJD, Berger JR, Katz DA. Neurosyphillis in HIV-positive and HIV-negative patients: neuroimaging findings. Am J Neuroradiol. 1995;16:703–711. [PMC free article] [PubMed] [Google Scholar]
  2. Chang KH, Han MH, Roh JK, Kim IO, Han MC, Kim CW. Gd-DTPA-enhanced MR imaging of the brain in patients with meningitis: comparison with CT. Am J Neuroradiol. 1990;11(1):69–76. [PMC free article] [PubMed] [Google Scholar]
  3. Hähnel S, Storch-Hagenlocher B, Kress B, Stippich C, Sartor K, Forsting M, Seitz A, Jansen O. Infectious diseases of brain parenchyma in adults: imaging and differential diagnosis aspects. Rofo. 2005;177(10):1349–1365. doi: 10.1055/s-2005-858544. [DOI] [PubMed] [Google Scholar]
  4. Kamra P, Azad R, Prasad KN, Jha S, Pradhan S, Gupta RK. Infectious meningitis: prospective evaluation with magnetization transfer MRI. Br J Radiol. 2004;77(917):387–394. doi: 10.1259/bjr/23641059. [DOI] [PubMed] [Google Scholar]
  5. Kastrup O, Wanke I, Maschke M. Neuroimaging of infections. NeuroRx. 2005;2(2):324–332. doi: 10.1602/neurorx.2.2.324. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Smirniotopoulos JG, Murphy FM, Rushing EJ, Rees JH, Schroeder JW. Patterns of contrast enhancement in the brain and meninges. Radiographics. 2007;27(2):525–551. doi: 10.1148/rg.272065155. [DOI] [PubMed] [Google Scholar]
  7. Srikanth SG, Taly AB, Nagarajan K, Jayakumar PN, Patil S. Clinicoradiological features of tuberculous meningitis in patients over 50 years of age. J Neurol Neurosurg Psychiatry. 2007;78(5):536–538. doi: 10.1136/jnnp.2006.095620. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Van de Beek D, de Gans J, Spanjaard L, Weisfelt M, Reitsma JB, Vermeulen M. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med. 2004;351(18):1849–1859. doi: 10.1056/NEJMoa040845. [DOI] [PubMed] [Google Scholar]
  9. Weisfelt M, Hoogman M, van de Beek D, de Gans J, Dreschler WA, Schmand BA. Dexamethasone and long-term outcome in adults with bacterial meningitis. Ann Neurol. 2006;60(4):456–468. doi: 10.1002/ana.20944. [DOI] [PubMed] [Google Scholar]

Articles from Inflammatory Diseases of the Brain are provided here courtesy of Nature Publishing Group

RESOURCES